KPMG is dedicated to assisting businesses of all sizes from biotechnology start-ups to large multinational pharmaceutical companies.
Life Sciences is dedicated to working with internationally leading organizations...
Our services are tailored to the issues that the industry, and your organization, experience.
Our member firms’ professionals have already helped many companies with the challenges of change management, sales force compliance, supply chain transformation, and mergers and alliances, to name a few.
KPMG industry-focused professionals have deep experience across the life sciences sector and continuously strive to keep abreast of industry trends, drivers and issues through knowledge sharing and industry insights programs. Our global network ensures that KPMG firms serve you with the same level of quality and consideration, whether you are operating in fast growing or emerging markets in the Americas, Asia or Europe.
The Pharmaceutical Sector
The rapidly changing landscape of the pharmaceutical sector is facing challenging times, coupled with increased government regulation.
Legislative changes on the horizon are expected to impact the sector and provide more onerous requirements for pharmaceutical manufacturers and suppliers alike. Increasingly, successful industry participants acknowledge the role of professional advisers in refining their business strategies and executing their plans. They know that the best advice is based on solid industry experience.
Our service offering:
Our dedicated industry-focused team combines audit, tax and information technology-related skillsets to provide our clients with a range of services including:
How we can help:
We work with some of the largest pharmaceutical companies around the globe to deliver professional services and unlock shareholder value. These clients depend on KPMG to augment their internal capabilities and obtain a fresh, independent perspective on important strategic and operational issues.
Medical device companies need to review their traditional approaches to innovation...
The life sciences supply chains that worked in the past now need to become more resilient, efficient, cost-effective and customer-centric.